Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
Recruiting
Observational Study
Open Angle Glaucoma (OAG)
Ocular Hypertension (OH)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Glaukos Corporation · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of Open-angle glaucoma
* 18 years of age or older
Exclusion Criteria:
* Subject who is breast-feeding or pregnant
Contacts